Skip to main content
. 2020 Feb 17;12(2):166. doi: 10.3390/pharmaceutics12020166

Figure 9.

Figure 9

In vitro simvastatin release analysis of the designed 3D bioprinted drug delivery scaffolds. (a,b) formulations 1–16, released drug up to 13 days; (c,d) formulations 17–26, released up to 16 days; (e) formulations 27–32, released up to 19 days; and (f) formulation 33–39, released over a duration of 20 days.